Accordingly, people with type 2 diabetes, cardiovascular disease, heart failure, or chronic kidney disease should be treated appropriately with an SGLT-2 inhibitor or GLP-1RA, even because more adults with type 2 diabetes in the US have suboptimal glycemic control now compared to 10 years ago, associated with a resurgence in vascular diabetic complications [32]
As more people seek convenient, confidential, and medically assisted weight loss solutions, Tirzepatide has become one of the most outstanding weight loss solutions in the current market
The patient increased the tirzepatide dose to optimize her diabetes management as suggested by the clinical team given the known risk of this medical comorbidity on surgical outcomes, particularly infection, given the medical device implantation
They can assess your symptoms, review your treatment plan, and suggest adjustments or additional interventions to help manage your fatigue
Body composition changes: Women may notice different patterns of body composition change compared to men